Mostrando 40,241 - 40,260 Resultados de 41,393 Para Buscar '"Thirty Three ', tiempo de consulta: 0.98s Limitar resultados
  1. 40241
    “…After thyroid hormonal levels were confirmed using radioimmunoassay and immunoradiometric assays, ulcer induction was done using 40 mg/kg intragastric single dose of Indomethacin in groups 2, 3 and 5. Stomachs were extracted after day 3 and 7 of ulcer induction for histological examination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 40242
    “…Diagnosis of acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and infective complications were according to the Berlin criteria, acute kidney injury network (AKIN) classification stage 2 and above and the American Burns Association guidelines. RESULTS: Thirty-five patients (17.3%) had inhalational burns out of 202 patients (63.4% male, 57.4% Chinese population). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 40243
    “…The NMA was conducted with software R 3.3.2 and STATA 14.0. RESULTS: Thirty randomized controlled trial (RCT) studies were analyzed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 40244
    “…The AUC/MIC and C(max)/MIC ratios in the patients for whom the pathogens were eradicated were significantly higher than those in the patients without the pathogens eradicated (75.3 [31.7–214.9] vs. 10.5 [3.8–66.1], Z = −3.938; 11.4 [4.2–17.8] vs. 1.4 [0.4–5.4], Z = −3.793; P < 0.001 for both). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 40245
    “…The maximal diazoxide dose was 7.1 ± 2.3 mg/kg/day (95% CI: 6.3-7.9). Diazoxide-treated neonates required a higher glucose infusion rate (GIR) compared to untreated neonates (16.6 ± 3.4 vs 10.4 ± 4.0 mg/kg/min, p<0.01), had a longer duration of intravenous fluids (15.9 ± 19.3 vs 7.8 ± 6.5 days, p<0.01), longer duration of hospitalization (32.8 ± 22.7 vs 20.4 ± 13.4 days, p<0.01), longer duration of carbohydrate supplementation (38.9 ± 40.4 vs 17.8 ± 21.4 days, p<0.01), and higher mean C-peptide levels (1.4 ± 0.9 vs 0.8 ± 0.5 ng/ml, p<0.01). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 40246
  7. 40247
  8. 40248
  9. 40249
  10. 40250
    por Fox, Philip R., Keene, Bruce W., Lamb, Kenneth, Schober, Karsten A., Chetboul, Valerie, Luis Fuentes, Virginia, Wess, Gerhard, Payne, Jessie Rose, Hogan, Daniel F., Motsinger‐Reif, Alison, Häggström, Jens, Trehiou‐Sechi, Emilie, Fine‐Ferreira, Deborah M., Nakamura, Reid K., Lee, Pamela M., Singh, Manreet K., Ware, Wendy A., Abbott, Jonathan A., Culshaw, Geoffrey, Riesen, Sabine, Borgarelli, Michele, Lesser, Michael B., Van Israël, Nicole, Côté, Etienne, Rush, John E., Bulmer, Barret, Santilli, Roberto A., Vollmar, Andrea C., Bossbaly, Maribeth J., Quick, Nadine, Bussadori, Claudio, Bright, Janice M., Estrada, Amara H., Ohad, Dan G., Fernández‐Del Palacio, Maria Josefa, Lunney Brayley, Jenifer, Schwartz, Denise S., Bové, Christina M., Gordon, Sonya G., Jung, Seung Woo, Brambilla, Paola, Moïse, N. Sydney, Stauthammer, Christopher D., Stepien, Rebecca L., Quintavalla, Cecilia, Amberger, Christophe, Manczur, Ferenc, Hung, Yong‐Wei, Lobetti, Remo, De Swarte, Marie, Tamborini, Alice, Mooney, Carmel T., Oyama, Mark A., Komolov, Andrey, Fujii, Yoko, Pariaut, Romain, Uechi, Masami, Tachika Ohara, Victoria Yukie
    Publicado 2018
    “…Risk assessed at 1, 5, and 10 years after study entry was 7.0%/3.5%, 19.9%/9.7%, and 23.9%/11.3% for CHF/ATE, and 6.7%, 22.8%, and 28.3% for cardiovascular death, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 40251
    “…Compared with the SBT group, the PBP group completed 27% more procedural steps (median [IQR], 31 [30-32] vs 24 [22-27]; P < .001) and made 73% fewer errors (median [IQR], 2 [1-3] vs 7 [5-8]; P < .001), 84% fewer critical errors (median [IQR], 1 [0-1] vs 3 [3-5]; P < .001), and 77% fewer all errors combined (errors plus critical errors) (median [IQR], 3 [1-3] vs 11 [8-12]; P < .001); 14 of the 15 PBP trainees (93%) demonstrated the predefined target performance level vs 0 of the 15 SBT trainees. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 40252
    “…The mean AOFAS score significantly improved from 55.5 ± 14.5 preoperatively to 86.3 ± 9.9 (P < 0.001). Comparison of radiographic outcomes showed that the lateral talar‐first metatarsal angle decreased by a mean of 19.1° ± 11.9° (P < 0.001), the calcaneal pitch angle increased by a mean of 5.4° ± 3.4° (P < 0.001), the talar declination angle decreased by a mean of 14.8° ± 9.9° (P < 0.001), the AP talar‐first metatarsal angle decreased by a mean of 15.6° ± 10.3° (P < 0.001), the AP talocalcaneal angle decreased by a mean of 7.2° ± 8.3° (P = 0.001), and the AP talonavicular coverage angle decreased by a mean of 20.4° ± 9.0° (P < 0.001). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 40253
    “…EXPOSURES: Guided by facilitators, participants identified their core values, as many as 3 actionable and realistic outcome goals, health-related barriers to these goals, and as many as 3 helpful and 3 bothersome health care activities. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 40254
    “…Demographic variables, clinical/paraclinical data, brain MRI, and Montreal Cognitive Assessment (MOCA) scores were examined as predictors of mRS and CASE scores in logistic and linear regression models, respectively. RESULTS: Thirty patients (60% male, median age = 68.5; interquartile range (IQR) = 63.0–75.0) were included, with a median follow-up time of 19.1 months (IQR = 5.3–47.1) The majority developed seizures (29, [97%]) and/or cognitive impairment (30, [100%]) and received acute (27, [90%]) and maintenance (23 [77%]) immunotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 40255
  16. 40256
    “…MATERIALS AND METHODS: Patients with mCRPC were treated with MVI-816 and pembrolizumab every 3 weeks (arm 3, n=20) or MVI-816 every 2 weeks and pembrolizumab every 4 weeks (arm 4, n=20). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 40257
    “…Network meta-analysis demonstrated improvements in VO(2)peak following centre-based (MD (95% CrI)=3.10 (2.56 to 3.65) mL/kg/min), home-based (MD=2.69 (1.67 to 3.70) mL/kg/min) and technology-enabled ExCR (MD=1.76 (0.27 to 3.26) mL/kg/min). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 40258
  19. 40259
    “…Good predictors of TCM were: normal LVEDVI (LVEDVI < 58 mL/m(2) (M) and < 52 mL/m(2) (F)) (odds ratio [OR] 5.2; 95% confidence interval [CI] 2.2–13.3, P < 0.001), fractional shortening < 30% (OR 3.5; 95% CI 1.4–9.2, P = 0.009), LAVI >40 mL/m(2) (OR 3.4; 95% CI 1.6–7.3, P = 0.001) and normal wall thickness left ventricle (OR 3.2; 95% CI 1.4–7.8, P = 0.008). 54% of patients with TCM demonstrated diastolic dysfunction at follow‐up, without differences from controls (54% vs. 43%, P = ns). 21% of patients with TCM showed persistent heart failure symptoms at follow‐up compared with 4.5% of controls, P = 0.004. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 40260
    “…In 20 (47.6%) patients, primary tumor waslocated in the adrenal gland, 19 (45.3%) had extra-adrenal PGL and head andneck PGL was seen in 3 (7.1%) patients. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS